This programme is designed to provide for a more realistic sample immunophenotyping process.
Please note that a laboratory who registers for Part One is automatically registered for Part Two and is required to complete both parts. However Part Two only registration is allowed for laboratories that do not routinely undertake immunophenotyping.
Individual registration for Part Two is also encouraged for continued professional development.
This part of the trial is designed to assess a laboratory’s ability to diagnose leukaemia using a full spectrum of laboratory tests. No samples are issued for this, the programme is totally web based. This part of the programme issues and examines a wide variety of cases. Each trial will consist of:
Participants are expected to use this information and in the diagnosis section provide a suitable diagnosis based on the World Health Organization (WHO) classification system.
This programme issues samples a minimum of 4 times per annum and a maximum of 6.
No activities in relation to this EQA programme are subcontracted.